---
schema_version: "secwatch.filing_event.v1"
accession: "0000010795-25-000069"
form_type: "8-K"
ticker: "BDX"
cik: "0000010795"
company_name: "BECTON DICKINSON & CO"
filed_at: "2025-08-07T23:59:59+00:00"
generated_at: "2026-05-17T17:03:24.462312+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# BD Q3 revenue $5.5B (+10.4%); adjusted EPS $3.68; raises FY guidance to $14.30-$14.45

## Summary
- Revenue of $5.5B, up 10.4% as reported and 3.0% organic; GAAP EPS $2.00, adjusted EPS $3.68.
- GAAP gross margin up 160 bps; adjusted gross margin up 50 bps; GAAP operating income up 46.6%.
- Company raises full-year adjusted diluted EPS guidance to $14.30-$14.45 (up $0.18 at midpoint); reaffirms organic revenue growth guidance.
- Expects to complete remaining $250M of $1B share buyback commitment by end of fiscal 2025.
- In July, announced definitive agreement to combine BD's Biosciences & Diagnostic Solutions business with Waters Corporation.

## SEC filing metadata
- accession: 0000010795-25-000069
- form_type: 8-K
- ticker: BDX
- cik: 0000010795
- company_name: BECTON DICKINSON & CO
- filed_at: 2025-08-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/10795/000001079525000069/0000010795-25-000069-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/10795/000001079525000069/bdx-20250807.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000010795-25-000069
- JSON: https://secwatch.observer/filing/0000010795-25-000069.json
- Plain text: https://secwatch.observer/filing/0000010795-25-000069.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.